Literature DB >> 14693786

Autologous peripheral retinal pigment epithelium translocation in patients with subfoveal neovascular membranes.

J C van Meurs1, E ter Averst, L J Hofland, P M van Hagen, C M Mooy, G S Baarsma, R W Kuijpers, T Boks, P Stalmans.   

Abstract

AIM: To evaluate the possibility of translocating autologous peripheral retinal pigment epithelial (RPE) cells and enhance their adhesion to improve functional outcome after choroidal neovascular membrane extraction in patients with subfoveal neovascular membranes.
METHODS: A prospective, non-controlled surgical study in eight consecutive patients operated between February and July 2001 with final data monitoring in July 2002. All patients had mixed subfoveal membranes of 2-4 disc diameters. Functional tests included Snellen vision and central fixation testing. During vitrectomy, after the extraction of the neovascular complex, 8 x 10(4)-16 x 10(4) RPE cells were removed from the periphery and translocated under the macula following the submacular injection of 2 microg of poly-L-lysine to promote adhesion of the cells.
RESULTS: With a follow up ranging from 3 months to 16 months, a pigmented area was seen in the extraction bed of the neovascular membrane in only one patient. Fixation was at the edge of the extraction bed in three patients. Vision remained the same in five patients and deteriorated in three (all with retinal detachment). Retinal detachment due to proliferative vitreoretinopathy occurred in three patients.
CONCLUSIONS: The translocation of autologous peripheral RPE cells after membrane extraction was technically possible in a sterile manner, but was associated with a high proliferative vitreoretinopathy rate and in the present series had no measurable positive effect on functional outcome.

Entities:  

Mesh:

Year:  2004        PMID: 14693786      PMCID: PMC1771957          DOI: 10.1136/bjo.88.1.110

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  27 in total

1.  Retinal pigment epithelial cell transplantation in RCS rats: normal metabolism in rescued photoreceptors.

Authors:  M M Lavail; L Li; J E Turner; D Yasumura
Journal:  Exp Eye Res       Date:  1992-10       Impact factor: 3.467

2.  Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1991-09

3.  Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2.

Authors:  Neil M Bressler
Journal:  Am J Ophthalmol       Date:  2002-01       Impact factor: 5.258

4.  Visual function after removal of subretinal neovascular membranes in patients with age-related macular degeneration.

Authors:  T Abe; M Yoshida; T Kano; M Tamai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2001-12       Impact factor: 3.117

5.  Choriocapillaris atrophy after experimental destruction of the retinal pigment epithelium in the rat. A study in thin sections and vascular casts.

Authors:  G E Korte; T Gerszberg; F Pua; P Henkind
Journal:  Acta Anat (Basel)       Date:  1986

6.  Engineering of cartilage tissue using bioresorbable polymer carriers in perfusion culture.

Authors:  M Sittinger; J Bujia; W W Minuth; C Hammer; G R Burmester
Journal:  Biomaterials       Date:  1994-05       Impact factor: 12.479

7.  Use of an oil-hydraulic microinjection pump for subretinal infusions.

Authors:  Judith Weichel; Monika Valtink; Katrin Engelmann; Gisbert Richard
Journal:  Ophthalmic Surg Lasers       Date:  2002 Jul-Aug

8.  Retinal separation, retinotomy, and macular relocation: II. A surgical approach for age-related macular degeneration?

Authors:  R Machemer; U H Steinhorst
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-11       Impact factor: 3.117

9.  Retinal pigment epithelium translocation after choroidal neovascular membrane removal in age-related macular degeneration.

Authors:  Paulo E Stanga; Andres Kychenthal; Frederick W Fitzke; Anthony S Halfyard; Roger Chan; Alan C Bird; George W Aylward
Journal:  Ophthalmology       Date:  2002-08       Impact factor: 12.079

10.  Visual results after surgical removal of subfoveal choroidal neovascular membranes.

Authors:  M A Thomas; J D Dickinson; N S Melberg; H E Ibanez; R S Dhaliwal
Journal:  Ophthalmology       Date:  1994-08       Impact factor: 12.079

View more
  35 in total

1.  Bone marrow-derived cells home to and regenerate retinal pigment epithelium after injury.

Authors:  Jeffrey R Harris; Gary A J Brown; Marda Jorgensen; Shalesh Kaushal; E Ann Ellis; Maria B Grant; Edward W Scott
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-05       Impact factor: 4.799

2.  Comparison of the growth potential of retinal pigment epithelial cells obtained during vitrectomy in patients with age-related macular degeneration or complex retinal detachment.

Authors:  Jan C van Meurs; Ellen ter Averst; Rebecca Croxen; Leo Hofland; P Martin van Hagen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-01-22       Impact factor: 3.117

Review 3.  [Pigment epithelial detachment in exudative macular degeneration: clinical characteristics and therapeutic options].

Authors:  A Lommatzsch
Journal:  Ophthalmologe       Date:  2010-12       Impact factor: 1.059

4.  [Autologous RPE-choroid translocation in exudative AMD. A case series of 10 consecutive patients].

Authors:  F Treumer; C Klatt; J Roider
Journal:  Ophthalmologe       Date:  2007-09       Impact factor: 1.059

Review 5.  A tissue-engineered approach towards retinal repair: scaffolds for cell transplantation to the subretinal space.

Authors:  Sara Royce Hynes; Erin B Lavik
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-02-19       Impact factor: 3.117

6.  Enhancing RPE Cell-Based Therapy Outcomes for AMD: The Role of Bruch's Membrane.

Authors:  Janosch P Heller; Keith R Martin
Journal:  Transl Vis Sci Technol       Date:  2014-07-03       Impact factor: 3.283

Review 7.  Induced pluripotent stem cell therapies for geographic atrophy of age-related macular degeneration.

Authors:  Hongjun Du; Siok Lam Lim; Seanna Grob; Kang Zhang
Journal:  Semin Ophthalmol       Date:  2011-05       Impact factor: 1.975

8.  COMBINED AUTOLOGOUS TRANSPLANTATION OF NEUROSENSORY RETINA, RETINAL PIGMENT EPITHELIUM, AND CHOROID FREE GRAFTS.

Authors:  Barbara Parolini; Dilraj S Grewal; Sajish J Pinackatt; Andrea Baldi; Attilio Di Salvatore; Gianluca Besozzi; Alessandro Finzi; Daniele Cardillo; Tamer H Mahmoud
Journal:  Retina       Date:  2018-09       Impact factor: 4.256

9.  Age-related macular degeneration: current treatments.

Authors:  Jean Pierre Hubschman; Shantan Reddy; Steven D Schwartz
Journal:  Clin Ophthalmol       Date:  2009-06-02

10.  Developing cellular therapies for retinal degenerative diseases.

Authors:  Kapil Bharti; Mahendra Rao; Sara Chandros Hull; David Stroncek; Brian P Brooks; Ellen Feigal; Jan C van Meurs; Christene A Huang; Sheldon S Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-26       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.